Artificial Intelligence in the Diagnosis of Cholesteatoma: A Systematic Review of Current Evidence

人工智能在胆脂瘤诊断中的应用:现有证据的系统性综述

阅读:1

Abstract

This systematic review evaluated the application of artificial intelligence (AI) in the imaging-based diagnosis of cholesteatoma. A comprehensive search of PubMed, Scopus, and Web of Science up to September 2025 identified 8,160 records, of which 7 studies met the inclusion criteria. Five studies used temporal bone CT, one investigated otoscopic images, and one assessed CT-based staging of mastoid extension. Reported internal validation accuracies were generally high (>90%), particularly with convolutional neural network (CNN) architectures, while external validations showed moderate performance (78-88%). A multicenter 3D convolutional neural network (CNN) with automated region-of-interest detection demonstrated consistent generalizability and aided surgical planning in prospective testing. The otoscopy-based model achieved high accuracy for differentiating cholesteatoma from normal membranes (>98%), though performance decreased when distinguishing it from other middle ear pathologies. Across studies, AI models often performed comparably to human readers, and explainability tools highlighted relevant diagnostic features. Most studies were retrospective and single-center, with limited external validation. Overall, AI shows strong potential for cholesteatoma diagnosis using CT and otoscopic imaging, but multicenter prospective studies with standardized evaluation and clinical impact assessment are needed before routine implementation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。